Presynaptic homeostatic plasticity rescues long-term depression after chronic Δ9-tetrahydrocannabinol exposure

被引:76
作者
Mato, S
Robbe, D
Puente, N
Grandes, P
Manzoni, OJ
机构
[1] INSERM, U378 Equipe Avenir, Inst Magendie Neurosci, F-33077 Bordeaux, France
[2] Basque Cty Univ, Fac Med & Dent, Dept Neurosci, Bilbao 48080, Spain
关键词
accumbens; cannabinoids; metabotropic glutamate receptor; glutamate; mice; LTD; long-term depression;
D O I
10.1523/JNEUROSCI.2294-05.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alterations of long-term synaptic plasticity have been proposed to participate in the development of addiction. To preserve synaptic functions, homeostatic processes must be engaged after exposure to abused drugs. At the mouse cortico-accumbens synapses, a single in vivo injection of Delta(9)-tetrahydrocannabinol (THC) suppresses endocannabinoid-mediated long-term depression. Using biochemical and electrophysiological approaches, we now report that 1 week of repeated in vivo THC treatment reduces the coupling efficiency of cannabinoid CB1 receptors (CB1Rs) to G(i/o) transduction proteins, as well as CB1R-mediated inhibition of excitatory synaptic transmission at the excitatory synapses between the prefrontal cortex and the nucleus accumbens (NAc). Nonetheless, we found that cortico-accumbens synapses unexpectedly express normal long-term depression because of a reversible switch in its underlying mechanisms. The present data show that, in THC-treated mice, long-term depression is expressed because a presynaptic mGluR2/3 (metabotropic glutamate receptor 2/3)-dependent mechanism replaces the impaired endocannabinoid system. Thus, in the NAc, a novel form of presynaptic homeostasis rescues synaptic plasticity from THC-induced deficits.
引用
收藏
页码:11619 / 11627
页数:9
相关论文
共 49 条
[1]   Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids [J].
Bacci, A ;
Huguenard, JR ;
Prince, DA .
NATURE, 2004, 431 (7006) :312-316
[2]   Chronic Δ9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain [J].
Breivogel, CS ;
Childers, SR ;
Deadwyler, SA ;
Hampson, RE ;
Vogt, LJ ;
Sim-Selley, LJ .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (06) :2447-2459
[3]   Synaptic gain control and homeostasis [J].
Burrone, J ;
Murthy, VN .
CURRENT OPINION IN NEUROBIOLOGY, 2003, 13 (05) :560-567
[4]   Regulation of neurotransmitter release by metabotropic glutamate receptors [J].
Cartmell, J ;
Schoepp, DD .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (03) :889-907
[5]   The mGlu2/3 receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing [J].
Cartmell, J ;
Monn, JA ;
Schoepp, DD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 400 (2-3) :221-224
[6]   Pharmacology and functions of metabotropic glutamate receptors [J].
Conn, PJ ;
Pin, JP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :205-237
[7]   A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens [J].
Fourgeaud, L ;
Mato, S ;
Bouchet, D ;
Hémar, A ;
Worley, PF ;
Manzoni, OJ .
JOURNAL OF NEUROSCIENCE, 2004, 24 (31) :6939-6945
[8]   Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists [J].
Fundytus, ME ;
Ritchie, J ;
Coderre, TJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (06) :1015-1020
[9]   LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats [J].
Helton, DR ;
Tizzano, JP ;
Monn, JA ;
Schoepp, DD ;
Kallman, MJ .
NEUROPHARMACOLOGY, 1997, 36 (11-12) :1511-1516
[10]  
Hoffman AF, 2003, J NEUROSCI, V23, P4815